HS Holdings Co., Ltd.

Equities

8699

JP3160790006

Banks

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
964 JPY +0.63% Intraday chart for HS Holdings Co., Ltd. +0.94% -4.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
New Russian owner of Hyundai's old St Petersburg plant launches Solaris production RE
HS Optimus Unit to Re-enter Singapore Door Market But Faces Price Pressures from Overseas Rivals MT
Iceland volcano leaves trail of damage RE
Iceland volcano fades but leaves residents in the cold RE
Hansoh Pharmaceutical Gets Nod to Trial Nephropathy Treatment Capsules MT
Iceland builds defences for a future of increased volcanic activity RE
Holcim takes 'rock star' North American business to Wall Street RE
Indian devotees splurge on jets, gold idols as Hindu temple opens RE
U.S. sanctions UAE shipping firm for violating Russian crude oil price cap RE
Hansoh Pharmaceutical Units Gets Clinical Trial Notice in China for Schizophrenia Treatment MT
Hap Seng Lending Arm's Loans Granted Reach MYR2.4 Billion As of End-2023 MT
AbbVie Says Phase 2 Trial of Lutikizumab Shows Higher Response Rates MT
GSK Enters Exclusive License Agreement With Hansoh for HS-20093 Cancer Antibody DJ
GSK: licensing agreement with Chinese company Hansoh CF
Hansoh Pharmaceutical Grants GSK Subsidiary Marketing License for Tumor Drug HS-20093 MT
U.S. Treasury Hits Three Shipowners With Russian Oil Price Cap Sanctions -- OPIS DJ
HS Optimus Unit Agrees to Acquire Sublease on Brunei Property for Nearly SG$2 Million MT
HS GovTech Solutions Announced Final Court Approval of Arrangement Agreement MT
Iceland prepares to shield geothermal plant from risk of volcanic eruption RE
China OKs Clinical Trial for Hansoh Pharmaceutical Units' Hypertrophic Cardiomyopathy Treatment MT
Global markets live: Foxconn, Roche, Eli Lilly, Chevron, Apple... Our Logo
Hansoh Pharmaceutical Grants GSK Subsidiary International Marketing License for HS-20089 MT
GSK, Hansoh Pharma Enter Exclusive License Deal for HS-20089 MT
GSK - GSK ENTERS EXCLUSIVE LICENSE AGREEMENT WITH HANSOH FOR HS-… RE
Hansoh Pharmaceutical Gets Nod to Test HS-20106 Injections MT
Chart HS Holdings Co., Ltd.
More charts
HS Holdings Co Ltd is a Japan-based company mainly engaged in the securities business. The Company operates in five segments. The Banking segment is engaged in deposit business and lending business. The Securities segment is engaged in the brokerage and commission of securities and derivative products, underwriting and sales of securities, handling of recruitment, sales of securities, handling of private offerings of securities, as well as other securities business. The Accounts Receivable Management business is engaged in the collection of perform credit management. Information Technology (IT) business is engaged in the development of mobile application and distribution of digital contents. The Other business is engaged in venture capital business and merger & acquisition business.
Sector
Banks
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 8699 Stock
  4. News HS Holdings Co., Ltd.
  5. HS GovTech Solutions Announced Final Court Approval of Arrangement Agreement